Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Farmitalia Carlo Erba SPA

Division of Pfizer Inc.

Latest From Farmitalia Carlo Erba SPA

Deal Watch: Endo Elbows In On Valeant’s Pursuit Of Salix

Bristol options rights to investigational prostate cancer immunotherapy, giving Bavarian Nordic additional funding to develop the candidate. Targacept finally calls it a day, in a reverse merger with Catalyst, while Arrowhead buys out the RNAi assets of Novartis.

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Italy
  • Parent & Subsidiaries
  • Pfizer Inc.
  • Senior Management
  • Roberto Bianchi, CEO
    Guido Sevra, Licensing Manager
    Manlio Carbucicchio, Corporate Marketing Director
    Romeo Roncucci, MD, Director, Research and Development
  • Contact Info
  • Farmitalia Carlo Erba SPA
    Phone: (39) 2 63331
    Foro Buonaparte 31
    Milan, -
    Italy
Advertisement
Advertisement
UsernamePublicRestriction

Register